Priority pharmaceutical and medical device investment opportunities within MPMED-SEZ — identified by the Ministry of Health, PIAT, and the Tanzania Investment Centre. Essential medicines and vaccines are PIAT strategic focus areas.
WHO-GMP facility for Tanzania’s essential medicines list — solid dosage, injectables, oral liquids, topicals. Only 19 domestic manufacturers vs 726 foreign; antibiotics 22.4% of registered medicines. TMDA 60-day fast-track. MSD 15% price preference and dedicated local tenders.
Active Pharmaceutical Ingredient production — no API or excipients manufacturing facilities exist in Tanzania or the entire EAC region; 100% of APIs are imported (TMDA/MSD). Chemical engineering infrastructure, dedicated API cluster. Zero domestic or regional competition.
High-volume production of gloves, syringes, IV sets, wound care, PPE, and surgical disposables. 157,444 import permits issued 2022–2025 — Tanzania’s largest import substitution opportunity by unit volume. Direct MoH public procurement contracts available.
Reagent manufacturing, rapid test kit assembly, and laboratory diagnostic equipment for malaria, HIV, TB, and NCD panels. 99% of diagnostics are imported (TMDA). WHO Emergency Use Listing pathway supported within the zone.
Purpose-built GMP-compliant cold-chain storage and distribution for vaccines, biologics, and temperature-sensitive medicines — serving MPMED-SEZ manufacturers and the wider East African supply chain.
Reagent manufacturing, rapid test kit assembly, and laboratory diagnostic equipment for malaria, HIV, TB, and NCD panels. 99% of diagnostics are imported (TMDA). WHO Emergency Use Listing pathway supported within the zone.
WHO-GMP facility for Tanzania’s essential medicines list — solid dosage, injectables, oral liquids, topicals. Only 19 domestic manufacturers vs 726 foreign; antibiotics 22.4% of registered medicines. TMDA 60-day fast-track. MSD 15% price preference and dedicated local tenders.
Active Pharmaceutical Ingredient production — no API or excipients manufacturing facilities exist in Tanzania or the entire EAC region; 100% of APIs are imported (TMDA/MSD). Chemical engineering infrastructure, dedicated API cluster. Zero domestic or regional competition.
High-volume production of gloves, syringes, IV sets, wound care, PPE, and surgical disposables. 157,444 import permits issued 2022–2025 — Tanzania’s largest import substitution opportunity by unit volume. Direct MoH public procurement contracts available.
Reagent manufacturing, rapid test kit assembly, and laboratory diagnostic equipment for malaria, HIV, TB, and NCD panels. 99% of diagnostics are imported (TMDA). WHO Emergency Use Listing pathway supported within the zone.
Purpose-built GMP-compliant cold-chain storage and distribution for vaccines, biologics, and temperature-sensitive medicines — serving MPMED-SEZ manufacturers and the wider East African supply chain.
Reagent manufacturing, rapid test kit assembly, and laboratory diagnostic equipment for malaria, HIV, TB, and NCD panels. 99% of diagnostics are imported (TMDA). WHO Emergency Use Listing pathway supported within the zone.
Join the next generation of pharmaceutical manufacturers shaping Africa’s healthcare future.
